☆ 4.8 Review

Systematic Review and Meta-Analyses of The Interaction Between HIV Infection And COVID-19: Two Years' Evidence Summary

FRONTIERS IN IMMUNOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Editorial Material Medicine, General & Internal

COVID-19 will continue but the end of the pandemic is near Comment

Christopher J. L. Murray

LANCET (2022)

添加到收藏夹

Review Biotechnology & Applied Microbiology

A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson

Rikin Patel et al.

Summary: This article discusses the mechanisms, side effects, and efficacy of COVID-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson. The vaccines have been shown to be safe and effective in protecting against moderate and symptomatic SARS-CoV-2 infection. It is important to continuously update the literature on these vaccines, especially as they are tested in different age groups and against emerging variants of the SARS-CoV-2 coronavirus.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

COVID-19 Vaccine Uptake Among People Living with HIV

Tim W. Menza et al.

Summary: People living with HIV are more susceptible to severe COVID-19 and should be prioritized for vaccination. However, in Oregon, it was found that younger individuals, Hispanic/Latinx individuals, and those who inject drugs or live in rural areas had lower vaccine uptake, while individuals engaged in care, enrolled in the AIDS Drug Assistance Program, and vaccinated against influenza had higher vaccine uptake. Therefore, greater advocacy, education, and care navigation are needed to increase COVID-19 vaccine access and uptake among PLWH.

AIDS AND BEHAVIOR (2022)

添加到收藏夹

Article Infectious Diseases

Clinical outcomes of patients with and without HIV hospitalized with COVID-19 in England during the early stages of the pandemic: a matched retrospective multi-centre analysis (RECEDE-C19 study)

Ming Jie Lee et al.

Summary: This study found differences in outcomes of people living with HIV (PLWH) hospitalized with COVID-19 compared to HIV-negative patients, however, these differences were ameliorated after adjusting for confounding comorbidities and demographic factors in a matched cohort.

HIV MEDICINE (2022)

添加到收藏夹

Article Infectious Diseases

COVID-19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID-19 pandemic in England

Alison E. Brown et al.

Summary: During the first wave of the pandemic in England, COVID-19 mortality among people with HIV was lower, but still higher than those without HIV after adjusting for demographic factors. Most people with HIV who died from/with COVID-19 had suppressed HIV viraemia and at least one comorbidity associated with poor COVID-19 outcomes.

HIV MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH

Roberta Gagliardini et al.

Summary: Compared to non-PLWH, PLWH hospitalized with COVID-19 showed milder symptoms, but no significant difference in clinical outcomes could be observed.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Immunology

Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study

Anna Maria Geretti et al.

Summary: This study compared the characteristics and outcomes of COVID-19 patients with and without HIV in the UK, finding that HIV-positive individuals had a higher risk of mortality, especially in those under 60 years old. Despite similar cumulative day-28 mortality rates, HIV-positive status was associated with increased mortality after adjusting for age and other variables.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa

Andrew Boulle et al.

Summary: In South Africa, living with HIV and having current tuberculosis were independently associated with increased COVID-19 mortality. These findings highlight the impact of these two diseases on COVID-19 risk and demonstrate the associations between age, sex, and other comorbidities with COVID-19 mortality.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Letter Immunology

COVID-19 Outcomes in Patients With Uncontrolled HIV-1 Infection

Leonardo Calza et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2021)

添加到收藏夹

Article Virology

Clinical outcomes of patients with COVID-19 and HIV coinfection

Sandhya R. Nagarakanti et al.

Summary: A retrospective study was conducted at Newark Beth Israel Medical Center to compare the clinical outcomes of HIV patients hospitalized for COVID-19 with a matched control group. The study found that HIV patients had similar in-hospital mortality, ICU admission rate, and need for mechanical ventilation compared to COVID-19 patients without HIV.

JOURNAL OF MEDICAL VIROLOGY (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Clinical Profile and Treatment of COVID-19 Patients: Experiences from an Ethiopian Treatment Center

Seid Getahun Abdela et al.

Summary: This study describes the clinical profile, treatment, and outcomes of COVID-19 patients in a treatment center in Ethiopia, revealing that most patients were asymptomatic but severe and critical cases were higher among symptomatic patients. More research is needed to assess the impact of HIV/AIDS on the severity and mortality of COVID-19.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2021)

添加到收藏夹

Article Infectious Diseases

Immune deficiency is a risk factor for severe COVID-19 in people living with HIV

Christian Hoffmann et al.

Summary: In people living with HIV, immune deficiency may be a risk factor for severe COVID-19, even with virological suppression. A current CD4+ T cell count below 350/mu l is associated with an increased risk of severe COVID-19, while a low CD4 T cell nadir is associated with mortality. There is no evidence for a protective effect of protease inhibitors or tenofovir alafenamide in this population.

HIV MEDICINE (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study

Jonathan Bergman et al.

Summary: This nationwide study in Sweden identified age, sex, and comorbidity as major risk factors for severe COVID-19. Additionally, hypertension, asthma, Down syndrome, and residence in a long-term care facility were associated with severe COVID-19.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study

Erjia Ge et al.

Summary: The study revealed that comorbidities play a significant role in the mortality and severity of COVID-19 patients, with a higher number of comorbidities associated with increased risks. Specifically, comorbidities were found to have a greater impact on younger individuals, emphasizing the importance of prioritizing vaccination for younger populations with multiple comorbidities.

PLOS ONE (2021)

添加到收藏夹

Article Immunology

HIV-1 Infection Does Not Change Disease Course or Inflammatory Pattern of SARS-CoV-2-Infected Patients Presenting at a Large Urban Medical Center in New York City

Justin Laracy et al.

Summary: Patients with HIV were more likely to be admitted from the emergency department when diagnosed with COVID-19, but did not show significant differences in 30-day mortality rate or mechanical ventilation rate compared to HIV-uninfected patients. HIV patients had higher erythrocyte sedimentation rates upon admission.

OPEN FORUM INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State

James M. Tesoriero et al.

Summary: This cohort study conducted in New York State found that persons living with diagnosed HIV had poorer outcomes related to COVID-19 compared to persons living without diagnosed HIV. Previous HIV diagnosis was associated with higher rates of severe disease requiring hospitalization, and hospitalization risk increased with progression of HIV disease stage.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Article Biology

HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection wave

Farina Karim et al.

Summary: Conflicting reports exist on the effects of HIV on COVID-19. In this study, it was found that participants living with HIV had more severe outcomes during the second wave of infection, with lower CD4 T cell counts and higher neutrophil to lymphocyte ratios associated with disease severity. Conversely, in the first wave, HIV seemed to modulate SARS-CoV-2 immune responses to a similar degree in both HIV negative and positive individuals.

ELIFE (2021)

添加到收藏夹

Article Immunology

Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data

Xueying Yang et al.

Summary: The study using N3C data in the US found that individuals with HIV infection have higher odds of COVID-19 death and hospitalisation, but lower odds of mild or moderate COVID-19. Factors such as older age, male gender, and specific racial/ethnic groups may exacerbate the risk of adverse COVID-19 outcomes among people with HIV.

LANCET HIV (2021)

添加到收藏夹

Article Infectious Diseases

Clinical features and risk factors associated with morbidity and mortality among patients with COVID-19 in northern Ethiopia

Hiluf Ebuy Abraha et al.

Summary: A significant proportion of COVID-19 cases in Ethiopia were asymptomatic, while older age, diabetes, cardiovascular disease, malignancy, surgery/trauma, and HIV infection were factors associated with the severity and in-hospital mortality of COVID-19. These findings could aid in developing appropriate patient management strategies.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis

Paddy Ssentongo et al.

Summary: Susceptibility to SARS-CoV-2 infection and mortality risk are higher among people living with HIV/AIDS compared to HIV-negative individuals. The beneficial effects of antiretroviral therapy in reducing infection and mortality risks for COVID-19 in PLWHA remain inconclusive. Prioritizing SARS-CoV-2 vaccination for persons with HIV is recommended to mitigate the increased risk associated with HIV infection.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Infectious Diseases

The impact of COVID-19 pandemic on HIV care continuum in Jiangsu, China

Lingen Shi et al.

Summary: This study evaluated the impact of the COVID-19 pandemic on the HIV care continuum in Jiangsu province, China, finding a significant decrease in HIV testing rates and new diagnoses during the first three months of implementing COVID-19 measures. Patients under 30 years old and migrants were more adversely affected by the COVID-19 policies. Further measures are needed to maintain the HIV care continuum in the face of the pandemic.

BMC INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort

Juan Berenguer et al.

Summary: The study found a SARS-CoV-2 antibody detection rate of 8.5% among people with HIV, with 45% of infections being asymptomatic. Birth in Latin American countries increased the likelihood of SARS-CoV-2 antibody positivity. Therapy with tenofovir disoproxil fumarate plus emtricitabine (TDF/FTC) may help prevent SARS-CoV-2 infection among PWH.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Article Immunology

Multicenter Study of Outcomes Among Persons With HIV Who Presented to US Emergency Departments With Suspected SARS-CoV-2

Christopher L. Bennett et al.

Summary: Among emergency department patients with HIV, clinical outcomes associated with SARS-CoV-2 infection are not worse when compared with patients without HIV, but SARS-CoV-2 infection increased the risk of death in patients with HIV.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2021)

添加到收藏夹

Article Infectious Diseases

Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19

Jacqui Venturas et al.

Summary: The study found that HIV is not a risk factor for moderate or severe COVID-19 disease, nor is it a risk factor for mortality. However, HIV-positive patients with COVID-19 requiring admission to hospital are more likely to be younger than their HIV-negative counterparts. These findings need to be confirmed in future, prospective studies.

JOURNAL OF INFECTION (2021)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 percent positivity and risk factors among people with HIV at an urban academic medical center

Eleanor E. Friedman et al.

Summary: Despite being more likely to be in higher-risk demographic groups, individuals with HIV were not found to have a higher likelihood of testing positive for SARS-CoV-2 in this study. The only significant differences seen between HIV-positive individuals who tested positive versus negative for SARS-CoV-2 were related to Hispanic/Latino ethnicity and the testing location.

PLOS ONE (2021)

添加到收藏夹

Article Immunology

Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study

Waasila Jassat et al.

Summary: The prevalence of hypertension, diabetes, HIV, and tuberculosis is high in the South African population. Factors associated with COVID-19 in-hospital mortality include age, HIV infection, past and current tuberculosis, among others.

LANCET HIV (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

COVID-19 Severity and COVID-19–Associated Deaths Among Hospitalized Patients with HIV Infection — Zambia, March–December 2020

Duncan Chanda et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Article Immunology

Clinical Features and Outcomes of Coronavirus Disease 2019 Among People With Human Immunodeficiency Virus in the United States: A Multicenter Study From a Large Global Health Research Network (TriNetX)

George A. Yendewa et al.

Summary: Overall, people with HIV had higher rates of poor COVID-19 outcomes, but were not more at risk of death compared to non-HIV-infected individuals. Older age and low CD4 count were predictors of adverse outcomes.

OPEN FORUM INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Infectious Diseases

Pregnancy and fertility-related adverse outcomes associated withChlamydia trachomatisinfection: a global systematic review and meta-analysis

Weiming Tang et al.

SEXUALLY TRANSMITTED INFECTIONS (2020)

添加到收藏夹

Article Immunology

Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study

Alexy Inciarte et al.

AIDS (2020)

添加到收藏夹

Article Immunology

Characteristics and outcomes of COVID-19 in patients with HIV: a multicentre research network study

Yousaf B. Hadi et al.

AIDS (2020)

添加到收藏夹

Article Immunology

Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City

Keith Sigel et al.

CLINICAL INFECTIOUS DISEASES (2020)

添加到收藏夹

Editorial Material Clinical Neurology

Rethinking high-risk groups in COVID-19

Anastasia Vishnevetsky et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

添加到收藏夹

Article Immunology

COVID-19 in Hospitalized Adults With HIV

Kate Stoeckle et al.

OPEN FORUM INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Immunology

Clinical Outcomes and Immunologic Characteristics of Coronavirus Disease 2019 in People With Human Immunodeficiency Virus

Hsi-en Ho et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

添加到收藏夹

Letter Infectious Diseases

CD4+T, CD8+T counts and severe COVID-19: A meta-analysis

Haipeng Zhang et al.

JOURNAL OF INFECTION (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

DEVELOPMENT OF A QUANTITATIVE SCORING METHOD FOR STROBE CHECKLIST

Dnyanesh Limaye et al.

ACTA POLONIAE PHARMACEUTICA (2018)

添加到收藏夹

Article Public, Environmental & Occupational Health

The Hispanic mortality paradox revisited: Meta-analysis and meta-regression of life-course differentials in Latin American and Caribbean immigrants' mortality

Eran Shor et al.

SOCIAL SCIENCE & MEDICINE (2017)

添加到收藏夹

Article Medicine, General & Internal

Converting an odds ratio to a range of plausible relative risks for better communication of research findings

Robert L. Grant

BMJ-BRITISH MEDICAL JOURNAL (2014)

添加到收藏夹

Review Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

PLOS MEDICINE (2009)

添加到收藏夹

Review Medicine, General & Internal

Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration

Jan P. Vandenbroucke et al.

PLOS MEDICINE (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.